Heads of Medicines Agencies / European Medicines Agency technical meeting on availability of authorised human medicines
Event
Human
Medicines
Date
- Thursday, 8 November 2018, All day
Location
- European Medicines Agency, Amsterdam, the Netherlands
This technical meeting between pharmaceutical industry stakeholders and regulators aims to gather technical feedback on the work of the Heads of Medicines Agencies (HMA) / European Medicines Agency (EMA) task force on the availability of medicines. The task force was set up to to provide strategic support and advice to tackle disruptions in supply of human and veterinary medicines and ensure their continued availability.
Problems with the availability of medicines have an impact not only on the supply chain but ultimately on healthcare systems, resulting in a significant impact on public health. Unavailability of medicines in the European Union, either because medicines are not marketed or because of supply disruptions, has been recognised by the HMA and EMA as an area of great concern affecting all stakeholder groups.
Attendance to this workshop is by invitation only.